Cargando…
In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin
BACKGROUND: Oxacillin continues to be an important agent in the treatment of staphylococcal infections; many generic products are available and the only requirement for their approval is demonstration of pharmaceutical equivalence. We tested the assumption that pharmaceutical equivalence predicts th...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897798/ https://www.ncbi.nlm.nih.gov/pubmed/20525378 http://dx.doi.org/10.1186/1471-2334-10-153 |